News & Analysis on Clinical Trial Services & Contract Research And Development
People on the move
By Melissa Fassbender
- Last updated on
Effective July 1, 2017, Dr. Dan Weng will be named Ergomed’s new CEO and a board director at which time Dr. Miroslav Reljanovic, Ergomed’s founder, will transition from CEO to executive vice-chairman
Weng joins the company from the Japanese CRO EPS Holdings, Inc. where he worked for six years, most recently as the company’s chairman, president, and CEO. He has also held executive level positions at MedPace, Icon Clinical Research, PharmaNet, and Quintiles
As he transitions to executive vice-chairman, Reljanovic will support Weng and the board to grow and develop the company’s offerings.